Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 4/20 | 0.84 |
| ▸ | MALT1 | Q9UDY8 | 5/20 | 0.71 |
| ▸ | RBP4 | P02753 | 1/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.57 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.57 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.54 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1250860 | 0.87 | TRPV1 (0.78) | TRPV1MALT1RBP4HSD11B1 | |
| SCHEMBL9942050 | 0.87 | TRPV1 (0.76) | TRPV1MALT1RBP4 | |
| SCHEMBL12910238 | 0.87 | TRPV1 (0.76) | TRPV1MALT1RBP4 | |
| SCHEMBL1252470 | 0.84 | TRPV1 (0.66) | TRPV1MALT1RBP4HSD11B1NOTUM | |
| SCHEMBL12909389 | 0.84 | MALT1 (0.69) | TRPV1MALT1RBP4HSD17B10KMT2A | |
| SCHEMBL4546335 | 0.84 | TRPV1 (0.63) | TRPV1MALT1RBP4HSD11B1RXFP1 | |
| SCHEMBL13714900 | 0.83 | MALT1 (1.00) | TRPV1MALT1HSD17B10 | |
| SCHEMBL3216080 | 0.79 | TRPV1 (0.69) | TRPV1RBP4HSD11B1 | |
| SCHEMBL12779444 | 0.78 | TRPV1 (0.61) | TRPV1MALT1RBP4RXFP1 | |
| SCHEMBL3932323 | 0.78 | TRPV1 (0.62) | TRPV1MALT1RBP4HSD11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8168827-B2 | Amide derivative | AJINOMOTO CO., INC. (JP) | 2012-05-01 | — | — | US | disclosed |
| US-20090258900-A1 | AMIDE DERIVATIVE | AJINOMOTO CO. INC (JP) | 2009-10-15 | — | — | US | disclosed |
| US-7572815-B2 | Amide derivative | AJINOMOTO CO., INC. (JP) | 2009-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090258900-A1 | AMIDE DERIVATIVE | NR0B1, NR0B2, NR1I3 | TRPV1 804/4885MALT1 2829/4885RBP4 1756/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.